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Abstract
This article will review selected herbal products used in traditional Chinese medicine, including medicinal mushrooms 
(巴西蘑菇 bā xī mó gū; Agaricus blazei, 雲芝 yún zhī; Coriolus versicolor, 靈芝 líng zhī; Ganoderma lucidum, 香蕈 
xiāng xùn; shiitake, Lentinus edodes, 牛樟芝 niú zhāng zhī; Taiwanofungus camphoratus), Cordyceps (冬蟲夏草 dōng 
chóng xià cǎo), pomegranate (石榴 shí liú; Granati Fructus), green tea (綠茶 lǜ chá; Theae Folium Non Fermentatum), 
garlic (大蒜 dà suàn; Allii Sativi Bulbus), turmeric (薑黃 jiāng huáng; Curcumae Longae Rhizoma), and Artemisiae 
Annuae Herba (青蒿 qīng hāo; sweet wormwood). Many of the discussed herbal products have gained popularity in 
their uses as dietary supplements for health benefits. The review will focus on the active constituents of the herbs and 
their bioactivities, with emphasis on the most recent progress in research for the period of 2003 to 2011.
Key words: Herbal Products, Medicinal Mushrooms, Dietary Supplements, Traditional Chinese Medicine (TCM)
*Correspondence to:
Dr. Kuo-Hsiung Lee, Natural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, 
North Carolina 27599-7568 USA, Tel: +1-919-962-0066, Fax: +1-919-966-3893, E-mail: khlee@unc.edu
Introduction
Herbal products have been used in traditional Chinese 
medicine (TCM) for thousands of years as foods to 
maintain good health and as drugs to treat disease. 
Because specific components in herbal products can 
exhibit different biological activities, the identification, 
characterization, and biological evaluations of these 
components can validate the traditional use of the 
herb, as well as also provide leads for new “single-
component” drug discovery and development. In 
addition, the daily use of herbal dietary supplements to 
promote good health is increasing rapidly worldwide. 
Thus, ancient TCM remedies should be reinvestigated 
using modern scientific methods to assure their efficacy 
and safety, and develop them as first-class dietary 
supplements, as well as new medicines.  
This article will review selected herbs used as 
functional foods or medicinal sources.  Their folkloric 
use, chemical composition, and currently identified 
biological activities will be discussed with emphasis on 
research during the period of 2003-2011.  The current 
review expands the prior article published in this journal 
on selected herbs classified as upper, middle, and lower 
classes in The Divine Husbandman's Herbal Foundation 
Canon (神農本草經 shén nóng běn cǎo jīng), as well as 
updates a prior similar review published by the author in 
2003 (Lee et al., 2003).
This is an open access article under the CC BY-NC-ND license.
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Figure 1. Structures of triterpenoids found in Ganoderma lucidum
Medicinal Mushrooms
Agaricus blazei Murill (巴西蘑菇 bā xī mó gū; 
Agaricaceae)
Agaricus blazei Murill (AbM) is an edible, medicinal 
mushroom of Brazilian origin. It has been cultivated 
commercially for the health food market.  This 
mushroom has been used in folk medicine against 
various diseases, including cancer, chronic hepatitis, 
diabetes, arteriosclerosis, and hyperlipidemia (and 
Weis, 1999a). Interest in the use of this mushroom 
and/or its extracts as dietary supplements has increased 
significantly, in part because of the confirmed studies 
of its antitumor, anticarcinogenic, antiviral, anti-
inflammatory, hypoglycemic, hypocholesterolemic, 
and antihypertensive effects (Fortes and Novaes, 
2006; Wasser and Weis, 1999a).  AbM mushroom 
extracts contain various active substances that promote 
stimulation of the immune system, in particular 
polysaccharides, such as proteoglycans, (1→3)-β- and 
(1→6)-β-D-glucans, (Ellertsen et al., 2006; Hetland et 
al., 2008; Kim et al., 2005; Lima et al., 2011).
Coriolus versicolor (雲芝 yún zhī; Polyporaceae)
Coriolus versicolor  has a long history of medicinal 
use in China and Japan and is one of the most researched 
and respected of the medicinal mushrooms from 
Europe to the Far East (Kidd, 2000). These mushrooms 
contain large quantities of β-glucans that stimulate the 
immune system (Gorin and Barreto-Bergter, 1983). The 
most active medicinal components are protein-bound 
β-glucan polysaccharides (PSKs, also known as Krestin 
in Japan) and polysaccharide-peptides (PSPs, yún zhī 
in China). Several clinical assays have reported that 
PSKs exhibit antitumor activity and synergistic effects 
in combined therapies (Katoh and Ooshiro, 2007; Choi 
et al., 2007; Oba et al., 2007).  Other studies have 
found antiviral activity against ectromelia virus and 
cytomegalovirus infections (Tsukagoshi et al., 1984), as 
well as cell-free human immunodeficiency virus (HIV) 
infection (Tochikura et al., 1987). PSKs also induce 
potent antimicrobial activity against Escherichia coli , 
Listeria monocytogenes , and Candida  (Sakagami et 
al., 1991).  PSPs have been more recently developed 
in China as anticancer and immunomodulatory agents 
(Ooi and Liu, 2000). PSPs also exhibit anti-oxidant 
properties, with strong scavenging effects on superoxide 
and hydroxyl radicals (Ooi and Liu, 2000).
Ganoderma (靈芝 líng zhī; Ganoderma lucidum, 
Polyporaceae)
Ganoderma (靈芝 líng zhī) has been widely used 
as a tonic and to treat various diseases, including 
chronic hepatopathy, hypertension, neurasthenia, 
insomnia, bronchitis, gastric ulcer, diabetes, and cancer 
in China, Japan, Korea, and other Asian countries 
for more than 2,000 years (Sanodiya et al., 2009). 
Because of Ganoderma's presumed health benefits 
and apparent absence of side effects, it has attained a 
reputation in the East as the ultimate herbal substance. 
G. lucidum contains numerous bioactive components, 
including triterpenoids, polysaccharides, nucleotides, 
sterols, steroids, fatty acids, proteins/peptides, and 
trace elements (Sanodiya et al., 2009).  The active 
triterpenoids from ling zhī are mainly ganoderic acids 
(Figure 1) (Kim and Kim, 1999).  They have been 
found to inhibit histamine release and cholesterol 
synthesis, as well as show antihypertensive, antitumor, 
and anti-HIV effects (Sandiya et al., 2009; Xu et al., 
2010). G. lucidum  also contains polysaccharides (β-D-
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glucans, heteropolysaccharides and glycoproteins), 
which can affect immune and immune-related cells, 
and show immunomodulatory, anti-angiogenic, and 
cytotoxic effects (Xu et al., 2011). In animal studies, 
polysaccharide fractions from G. lucidum  have 
demonstrated potential hypoglycemic and hypolipidemic 
activities (Mohammed et al., 2007; Sanodiya et al., 
2009).
Lentinus (香蕈 xiāng xùn; Shiitake, Lentinus edodes, 
Marasmiaceae)
Shiitake mushrooms are currently one of the five 
most cultivated edible mushrooms in the world 
(Chang, 1999). They have been used medicinally 
and as healthy food for thousands of years in Japan, 
China, and Korea, and are now becoming popular in 
nutritional and medicinal products throughout Europe 
and North America. Many health benefits have been 
ascribed to shiitake mushrooms and their constituents. 
The polysaccharide lentinan [β-(1→3)-D-glucan], 
shiitake mushroom mycelium, and culture media 
extracts (LEM, LAP, and KS-2) (Wasser, 2002) have 
demonstrated strong antitumor activities orally and 
by injection in both animals and humans. Lentinan is 
also effective against various bacterial, viral (including 
AIDS), and parasitic infections (Ngai and Ng, 2003). 
LEM is also useful in the treatment of AIDS, as 
studies have shown that it can inhibit HIV infections 
of cultured human T cells, and potentiate the effects 
of AZT against viral replication in vitro  (Tochikura 
et al., 1988). Water-soluble lignins from EP3 and 
EPS4 from shiitake mushroom mycelium have shown 
antiviral and immunomodulating effects (Hanafusa 
et al., 1990). Centinamycins A and B have also been 
identified as antibacterial polyacetylene compounds in 
shiitake mushroom (Wasser, 2005). Eritadenine (Figure 
2), a cholesterol-lowing compound found in shiitake 
mushrooms (Yang et al., 2002), also possesses antiviral 
properties (Wasser and Weis, 1999b).
Taiwanofungus camphoratus (牛樟芝 niú zhāng zhī; 
Coriolaceae)
Taiwanofungus camphoratus  is an indigenous 
mushroom in Taiwan, and has been used as a folkloric 
medicine since the 18th century for treating food 
and drug intoxications, diarrhea, abdominal pain, 
hypertension, itchy skin, and hepatoma (Wu et 
al., 1997). The reported biological activities for T. 
camphoratus  include anticancer, antihepatotoxic, 
antihypertensive, anti-inflammatory, anti-oxidant, and 
neuroprotective. In addition, T. camphoratus produces 
a synergistic effect when combined with the drugs 
trichostatin A, lovastatin, and paclitaxel (Chen et al., 
2010; Peng et al., 2008).  Chemical constituents and 
their pharmacological properties are listed below.
(1)  Triterpenoids:  Recently, 10 new triterpenoids, 
camphoratins A–J, and 13 known triterpenoids were 
isolated from the fruiting body of T. camphoratus 
(Shi et al., 2011; Wu et al., 2010). Camphoratins 
                                           Figure 3. Structures of various chemical compounds found in Taiwanofungus camphoratus
Figure 2. Structure of eritadenine found in Lentinus edodes
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B-F and zhankuic acid A showed moderate to potent 
cytotoxicity, with EC50 values ranging from 0.3 to 
3 μM against KB and KB-VIN human cancer cell 
lines (Wu et al., 2010). Zhankuic acids A and C 
and methyl antcinate B (Figure 3) displayed tumor-
specific cytotoxicity against colon, breast, liver, 
and lung cancer cell lines. Furthermore, when these 
three compounds were combined at a concentration 
of 4 μM, a synergistic cytotoxic effect was seen 
against colon cancer HT-29 cells (Yeh et al., 2009). 
Camphoratins F and J, zhankuic acid A and its 
methyl ester (Figure 3), antcins A and C, methyl 
antcinate H, and methyl 4α-methylergost-8,24(28)-
dien-3,11-dion-26-oate exhibited anti-inflammatory 
effects by inhibiting NO-production with IC50 values 
of less than 5 μM (Wu et al., 2010).  These results 
may substantiate the use of T. camphoratus in TCM 
for the treatment of inflammation and cancer-related 
diseases, and prompt further investigation of its 
triterpenoid constituents as cancer chemotherapeutic 
agents or as anti-inflammatory drugs to treat NO-
dependent neurodegenerative disorders.
(2)  Benzenoids:  In 2011, Shi et al. isolated five new 
benzenoids, benzocamphorins A–E and seven known 
benzenoids from the fruiting body of T. camphoratus 
(Shi et al., 2011). Antrocamphin A showed moderate 
cytotoxicity against MCF-7 cells with ED50 values 
of 3.4 μg/mL (threshold for activity is considered 4 
μg/mL). Antrocamphin A, benzocamphorin B, and 
2,2′,5,5′-tetramethoxy-3,4,3′,4′-bimethylenedioxy-
6,6′-dimethylbiphenyl (Figure 3) also exhibited 
effective anti-inflammatory activity.
(3)  Maleic and succinic acid derivatives:   Two 
maleimide derivatives, antrodins B and C (Figure 3), 
were isolated from the mycelium of T. camphoratus. 
They showed appreciable cytotoxic activity against 
the LLC tumor cell line (Nakamura et al., 2004).
(4)  Polysaccharides:  Polysaccharides from mycelia of 
T. camphoratus inhibited U937 cell growth by 55.3% 
via activation of mononuclear cells. Intraperitoneal 
and oral  adminis t ra t ion of  T.  camphoratus 
polysaccharides (100 and 200 mg/kg, respectively) 
significantly suppressed tumor growth to 69.1% and 
58.8%, respectively, in sarcoma 180-bearing mice 
(Liu et al., 2004). T. camphoratus  polysaccharides 
also inhibited cyclin D1 expression in endothelial 
cells by inhibiting vascular endothelial growth 
factor receptor signaling, and thereby suppressing 
angiogenesis (Cheng et al., 2005). In addition, the 
sulfated polysaccharides inhibited in vitro Matrigel 
tube formation in an angiogenesis model, and 
effectively prevented serum-deprived apoptosis, 
using a stress model of serum deprivation-induced 
apoptosis in neuronal-like PC12 cells (Cheng et al., 
2009).
Cordyceps (冬蟲夏草 dōng chóng xià cǎo; Cordyceps 
sinensis, Claviceptaceae)
Cordyceps sinensis (Bark) Sacc.Link (Claviceptaceae) 
(Ascomycetes) is a parasitic fungus. It invades and 
kills the larva of some Hepiaidae species, eventually 
forming a parasitic complex that contains the remains 
of the caterpillar and the stroma of the fungus. The 
parasitic complex is also known as “winter worm 
summer grass”, because of its appearance during 
different seasons. It is mostly found in Tibet, Qinghai, 
Sichuan, Yunnan and Gansu provinces of China. In 
TCM, Cordyceps is commonly used to “replenish the 
kidney and soothe the lung”, as well as to treat fatigue 
(Lull et al., 2005; Wojcikowski et al., 2006; Zhang 
and Wu, 2007). It also can be used to treat conditions 
such as night sweating, hyposexuality, hyperglycemia, 
hyperlipidemia, asthenia after severe illness, respiratory 
disease, and renal dysfunction or failure, arrhythmias 
and other heart and liver diseases (Liu and Shen, 2003). 
Although the pharmacologically active components 
of C.sinensis have not been fully elucidated, at least 
two chemical constituents, cordycepin and cordycepic 
acid (Figure 4), have been identified and proposed as 
important active components (Huang et al., 2003; Zhu 
et al, 1998).  Cordycepic acid was originally identified 
as 1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid 
(Chatterjee et al., 1957), but later was re-identified as 
D-mannitol (Sprecher and Sprinson, 1963) (Figure 4). 
C. sinensis  also contains polysaccharides, nucleotides, 
Figure 4. Structures of cordycepin and cordycepic acid found in 
Cordyceps sinensis
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ergosterol crude protein and amino acids, fatty acids, 
and metal elements. The chemical components, 
pharmacological effects, and developmental products 
of Cordyceps fungi have been reviewed (Zhou et al., 
2009).
Pomegranate (石榴 shí liú; Granati Fructus, the fruit 
of Punica granatum, Punicaceae)
Pomegranate is the fruit of Punica granatum, and 
has long been cultivated and consumed by different 
cultures. Anatomically, this plant can be divided into 
seven parts, seed, juice, peel, leaf, flower, bark, and 
roots, and each part exhibits pharmacologic effects. 
The plant has been used as an antihelmintic and 
vermifuge, to eliminate parasites, to treat mouth ulcers, 
diarrhea, acidosis, dysentery, hemorrhage, microbial 
infections, and respiratory pathologies, and as an 
antipyretic. The primary chemical components and their 
potential beneficial effects have recently been reviewed 
(Lansky and Newman, 2007; Martos et al., 2010). For 
example, the flanovol quercetin inhibited lung cancer 
cell growth via G2/M arrest and apoptosis induction, 
while kaempferol reduced expression of TNF-α and 
interleukin 1β gene in tumor cells (Figure 5). The two 
compounds acted synergistically to inhibit breast cancer 
proliferation.
Green tea (綠茶 lǜ chá; Theae Folium Non Fermentatum, 
Camellia sinensis, Theaceae)
Green tea is produced from the fresh nonfermented 
leaves of Camellia sinensis  (Theaceae) and is a very 
popular beverage worldwide. Its bioactive components 
include green tea polyphenols (GTPs) (Figure 6), known 
as catechins, which are divided into four structural 
groups, (-)-epigallocatechin-3-gallate (EGCG), 
(-)-epigallocatechin (EGC), (-)-epicatechin-3-gallate 
(ECG), and (-)-epicatechin (EC) (Sano et al., 2001). 
GTPs have been studied for four main biological 
activities: cancer chemoprevention, antibacterial 
activity, antiviral effects, and neuroprotection.
(1)  Cancer, Chemoprevention: GTPs been linked to 
the prevention of many cancers, including lung, 
colon, esophagus, mouth, stomach, small intestine, 
kidney, pancreas, and mammary glands (Chacko 
et al., 2010).  EGCG, the major GTP, showed 
potent cancer-preventive effects both in vitro  and 
in vivo  (Yang et al., 2000). EGCG modulated 
the function of certain transcription factors, 
namely NF-κB and activator protein (AP-1) in 
cell culture and animal studies (Dong et al., 1997; 
Gupta et al., 2004; Nomura et al., 2000). NF-κB 
facilitated the transcription of genes involved in 
inflammation, immunity, and carcinogenesis. EGCG 
also modulated other multiple signaling pathways 
at various cellular levels, ultimately leading to 
apoptosis, cell cycle arrest, growth inhibition, anti-
angiogenesis, and metastasis inhibition. Which of 
EGCG’s multiple molecular targets are most critical 
for its chemopreventive actions has not been fully 
established. Kim et al. recently summarized the 
molecular targets modulated by EGCG (Kim et al., 
2010). 
(2)  Antibacterial Activity: EGCG has possible use 
as an adjuvant in antibacterial therapy, because 
it dramatically enhanced tetracycline activity in 
Staphylococci  by reducing tetracycline efflux from 
bacterial cells (Sudano Roccaro et al., 2004).
(3)  Antiviral Activity: GTPs, in particular EGCG, 
have been studied against various viruses. EGCG 
interrupted the HIV-1 life cycle with a destructive 
effect on the viral particles. Post-adsorption entry 
and reverse transcriptase in THP-1 cells were 
significantly inhibited at EGCG concentrations 
over 1 μM, and protease kinetics were suppressed 
at a concentration higher than 10 μM in a cell-free 
study (Yamaguchi et al., 2002). EGCG also inhibited 
Figure 5. Structures of two active flavonols found in Punica granatum
Figure 6. Structures of green tea polyphenols (GTPs) found in Green 
Tea (Camellia sinensis)
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influenza virus by binding to hemagglutinin (HA) 
spike proteins, thus, blocking viral attachment to 
the target cell receptors (Mukoyama et al., 1991). 
Against adenovirus infection and the viral protease 
adenain, EGCG displayed an IC50 of 25 μM and a 
therapeutic index of 22 in Hep2 cells (Weber et al., 
2003). In other studies, rotavirus, poliovirus, and 
herpes simplex virus were also inhibited by EGCG 
and tea extracts (Mukoyama et al., 1991; Yamaguchi 
et al., 2002).  
(4)  Neuroprotective Activity: In studies by Weinreb 
et al., EGCG appeared to affect the mortality of 
neuronal cells, and thus, possibly have an effect on 
neurodegenerative diseases, such as Alzheimer’s 
and Parkison’s diseases, which are associated with 
oxidative damage and iron accretion. Because 
mitochondria play a central role in oxidative stress–
induced apoptosis, EGCG-mediated inhibition of 
apoptosis might implicate mitochondrial targets 
(Weinreb et al., 2004).
Garlic (大蒜 dà suàn; Allii Sativi Bulbus, Allium 
sativum, Liliaceae)
Garlic (Allium sativum), belonging to the family 
Liliaceae, is highly regarded throughout the world. 
Originally from Central Asia, garlic is one of the 
earliest cultivated plants and is used for both culinary 
and medicinal purposes. It has been used to treat 
infections and wounds, due to its antibacterial properties 
(Goncagul and Ayaz, 2010) and various disease states, 
including diarrhea, rheumatism, diabetes, and heart 
disease (Aviello et al., 2009). Its beneficial effects on the 
cardiovascular system, particularly the prevention and 
treatment of artherosclerosis, include antithrombotic, 
blood pressure lowering, and hypolipidemic properties 
(El-Sabban and Abouazra, 2008; Ginter and Simko, 
2010).  Additionally, antiviral, anti-oxidant, free radical 
scavenging, hypoglycemic, and anticancer properties 
have also been demonstrated (Bongiorno et al., 2008; 
Tripathi, 2009). Organic sulfur compounds found in 
garlic may promote early mitotic arrest followed by 
apoptotic cell death without affecting normal cells 
(Ban et al., 2007; Jakubikova and Sedlak, 2006). 
Modulation of NF-κB (Ban et al., 2007) and alteration 
of the microtubule network (Cerella et al., 2011) have 
been found as possible mechanisms for these activities. 
Taken together, these findings indicate a promising 
potential for the use of garlic-derived sulfur compounds 
in chemoprevention and chemotherapy, as well as 
an immune booster (Butt et al., 2009). The two most 
studied chemical constituents are allicin (produced 
from the alliin in fresh garlic by the enzymatic action 
of alliinase when garlic is chopped) and ajoene (Figure 
7). Other bioactive components are diallyl disulfide 
and triallyl trisulfide (Lei et al., 2010), as well as 
S-allylmercaptocysteine and thiacremonone (Ban et al., 
2007) (Figure 7).
Turmeric (薑黃 jiāng huáng; Curcumae Longae 
Rhizoma, Curcuma longa, Zingiberaceae)
Curcuma longa  (Zingiberaceae) is a plant in the 
ginger family and is heavily used as a spice (turmeric) 
to flavor food. Its main constituent is the natural product 
curcumin [diferuloylmethane, 1,7-bis-(4-hydroxy-3-
methoxyphenyl)-1,6-heptadiene-3,5-dione], which is 
responsible for much of turmeric’s flavor, yellow color, 
and bioactivity. Besides curcumin, other curcuminoids, 
such as demethoxycurcumin, bisdemethoxycurcumin, 
cyclocurcumin (Kiuchi et al., 1993), and calebin A (Kim 
et al., 2001) are also found in C. longa  (Figure 8).  
Figure 7. Structures of organic sulfur compounds found in Garlic 
(Allium sativum)
Figure 8. Structures of curcumin and other natural curcuminoids from 
Curcuma longa
7Lee et al . / Journal of Traditional and Complementary Medicine 2 (2012) XXX-XXX
Known as jiāng huáng in Chinese, C. longa rhizome 
has been used as a safe and non-toxic traditional 
medicine in Asia for centuries to treat diarrhea, 
intermittent fever, edema, bronchitis, colds, worms, 
leprosy, kidney inflammation, and cystitis, and as an 
anticancer treatment (Aggarwal et al., 2003; Anand et 
al., 2008; Cheng et al., 2001; Uehara et al., 1992). The 
unique structure of curcumin also makes this molecule 
biologically distinctive. Modern scientific research in 
mammalian cells and animals has confirmed its broad 
scope of biological activities and numerous therapeutic 
effects, including anti-oxidant (Ruby et al., 1995), anti-
inflammatory (Aggarwal and Harikumar, 2009; Itokawa 
et al., 2008; Kohli et al., 2005), and particularly, 
anticancer effects (Ravindran et al., 2009).  
Many in vitro  studies have reported that curcumin 
is effective against various cancer cell lines, including 
breast (hormone-dependent, hormone-independent, 
and multidrug-resistant) (Anand et al., 2008), gastric 
(Anand et al., 2008), head and neck squamous (Anand 
et al., 2008; Wilken et al., 2011), pancreatic (Kamohara 
et al., 2007), colorectal (Anand et al., 2008; Villegas 
et al., 2008), urinary bladder (Kamat et al., 2007; Sun 
et al., 2004), kidney (Jiang et al., 1996; Jung et al., 
2005), cervical (Anand et al., 2008; Roy et al., 2002), 
ovarian (Wahl et al., 2007), lung (Lee et al., 2005), 
oral (Atsumi et al., 2005; Atsumi et al., 2006), and 
thymic (Bhattacharyya et al., 2007).  It also can inhibit 
cellular proliferation and enhance apoptosis (Reuter 
et al., 2008; Skommer et al., 2006; Wei et al., 2004). 
In prostate cancer cells, such as LNCaP, DU145, C4-
2B, and PC3, curcumin up-regulated the expression of 
the androgen receptor (AR), AP-1, cyclin D1, NF-κB 
and cAMP response element binding (CREB) protein 
and EGFR-TK activity (Anand et al., 2008). Recently, 
some curcumin derivatives (such as 1-4 in Table 1) were 
reported to be more potent anti-prostate cancer agents 
than curcumin and to act by inducing or enhancing 
AR degradation (Lin et al., 2006; Ohtsu et al., 2003). 
Curcumin can also modulate/activate numerous target 
proteins, including transcription factors (e.g., NF-κB, 
STAT-3, AP-1, NFR-2, PPR-γ, HIF-1), receptors (e.g., 
MMP, iNOS, GST, ATPase), and growth factors (e.g., 
EGF, NGF, HGF, PDGF) (Goel et al., 2008; Hatcher et 
al, 2006).   
One significant advantage of curcumin as an 
antitumor and chemopreventive agent is its differential 
effects on normal cells, such as endothelial cells, 
lymphocytes, hepatocytes, fibroblasts, thymocytes, and 
mammary epithelial cells (Santel et al, 2008; Watson et 
al., 2008; Uddin et al., 2005). The reason why curcumin 
selectively kills tumor cells but not normal cells still 
remains unclear; however, some suggestions have been 
proposed: (1) cellular uptake of curcumin is higher in 
tumor cells than in normal cells (Kunwar et al., 2008), 
(2) the glutathione levels in tumor cells tend to be lower 
than normal cells, which promotes the sensitivity of 
tumor cells to curcumin (Syng-Ai et al., 2004), and (3) 
most tumor cells express constitutively active NF-κB 
and mediate their survival (Lin et al., 2007).
In 1985, Kuttan et al. reported the first in vivo study 
showing the anticancer activity of curcumin in an 
ascites mice model of Dalton’s lymphoma (Kuttan et 
al, 1985).  Since then, extensive in vivo studies have 
investigated the chemopreventive, as well as anticancer, 
effects of curcumin. Their results revealed that curcumin 
has potential against many cancers, such as lymphoma/
leukemia, colon, esophageal, liver, lung, oral, skin, 
breast, and prostate cancers, etc., in animal and tumor 
models (Goel et al., 2008).  
Clinical trials of curcumin in cancer patients have 
been conducted worldwide for many years. Several 
reports demonstrated that curcumin is effective against 
myeloma, colorectal, pancreatic, and prostate cancers 
in humans (Anand et al., 2008; Anuchapreeda et al., 
2006; Goel et al., 2008). In a recent phase I/II study, 
curcumin was administrated orally in combination with 
gemcitabine to treat gemcitabine-resistant pancreatic 
cancer. The study demonstrated that this combination 
chemotherapy is safe and feasible in pancreatic cancer 
patients (Kanai et al., 2011). 
Table 1. Reduction of AR protein expression in prostate cancer cells 
and cytotoxicity of curcumin analoguesa
Cmpd R R’
LNCaP 
IC50 (μМ)
PC-3 
IC50 (μМ)
LNCaPb 
transactivation
(%)
PC-3+wt.ARb 
transactivation 
(%)
Curcumin OH H 3.8 7.7 NDc ND
1 OCH3
CH
=CHCOOEt
0.2 1.0 6 40
2 OCH3
CH
=CHCN
0.2 0.7 42 68
3 OCH3
CH
=CHCONHEt
0.6 1.2 ND ND
4 OCH3
CH
=CHCH2OH
0.2 1.3 ND ND
a Data cited from Lin et al., 2006.
b  Compounds were tested at 5 µM concentration for inhibiting cell 
transactivation (treated with DHT 1 nM) by detection of luciferase 
activity.
c ND = Not Determined.
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Artemisiae Annuae Herba (青蒿 qīng hāo; sweet 
wormwood, Artemisia annua, Asteraceae)
Artemisia annua  Linn. (sweet wormwood; Chinese 
wormwood) is a member of the Asteraceae family 
of plants (formerly Compositae) and is the source of 
the Chinese medicine Qinghao. A. annua  contains 
various terpenoids (particulary highly oxygenated 
sesquiterpene lactones), flavonoids, coumarins, and 
other shikimate metabolites. The presence of numerous 
terpene allylic hydroperoxides and endoperoxides is 
a characteristic phytochemical feature of this species 
(Brown, 2010). Artemisinin is one such highly 
oxygenated sesquiterpene lactone found uniquely in 
A. annua . It is a well known antimalarial drug, with 
no known side effects. The unique 1,2,4-trioxane ring 
structure found in artemisinin and its analogues, such 
as artemether, arteether, and artesunate, (Figure 9) is 
necessary for the antimalarial activity. This important 
compound was isolated in the early 1970s based on 
information recorded long ago about Qinghao in the 
TCM archive, “Emergency Prescriptions Kept Up One's 
Sleeve”, by the famous physician Ge Hong (284-363) 
(Hsu, 2006). Although artemisinins also show cytotoxic 
activity against cancer cells by various mechanisms 
of action (Efferth, 2006), the antimalarial activity is 
the prominent medicinal use (Klayman et al., 1984; 
Sriram et al., 2004). It should be noted that the Lasker 
Foundation awarded the 2011 Lasker~DeBakey Clinical 
Medical Research Award to Tu Youyou (China Academy 
of Chinese Medical Sciences, Beijing), who first dove 
back into the ancient literature and led to the isolation 
of qinghaosu as a potent antimalarial drug through a 
group effort in China (http://www.laskerfoundation.
org/awards/2011_c_description.htm). It should also 
be mentioned that a significant contribution was made 
by Dr. Yi Zhao with regard to the elucidation of the 
pharmacological effect as well as the mechanism of 
action of qinghaosu as evidenced in his academic papers 
entitled Studies on Artemisia annua  L./Qinghaosu, 
Guangxi TCM University, China (Zhao et al., 1986; 
Zhao et al., 1987).
Conclusion
As part of the TCM and other folk medicine systems, 
many plant and fungal species are used as foods and 
dietary supplements to promote good health, as well as 
to prevent or treat many diseases. Relatively nontoxic 
herbal products are particularly desireable for alleviating 
chronic health effects. However, the pharmacological 
effects of TCM and other natural products on the 
human body must be ascertained, toxicological studies 
must be performed, authenticity must be verified, and 
quality control standards must be maintained to ensure 
both maximal safety and efficacy to treat both chronic 
and acute conditions. Modern scientific methodology 
and medicinal chemistry approaches will continue to 
identify and evaluate the bioactive components found in 
TCM prescriptions, and validate their use as sources of 
new, effective, and safe world-class new medicines and 
dietary supplements.  
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